表紙
市場調査レポート

世界における疼痛管理薬市場

Global Pain Management Drugs Market 2014-2018

発行 TechNavio (Infiniti Research Ltd.) 商品コード 298326
出版日 ページ情報 英文 79 Pages
即納可能
価格
本日の銀行送金レート: 1USD=106.12円で換算しております。
Back to Top
世界における疼痛管理薬市場 Global Pain Management Drugs Market 2014-2018
出版日: 2014年03月14日 ページ情報: 英文 79 Pages
概要

世界の疼痛管理薬市場は、2013年から2018年にかけて、3.84%の複合年間成長率(CAGR)で拡大する見込みです。この成長の背景には、世界的な人口の高齢化があります。しかし、ジェネリック医薬品の台頭が、この市場の成長を阻害する要因になるかも知れません。

当レポートでは、世界における疼痛管理薬市場の現状と将来の見通し、疼痛の種類/地域別の動向、市場の成長因子と課題、主要ベンダーの分析などを提供しており、概略以下の構成でお届けします。

第1章 エグゼクティブサマリー

第2章 略語リスト

第3章 調査範囲

  • 市場概要
  • 主な製品

第4章 市場調査手法

  • 市場調査プロセス
  • 調査手法

第5章 イントロダクション

第6章 市場情勢

  • 市場概要
  • 市場規模と予測
  • ファイブフォース分析

第7章 カテゴリー別の市場区分

  • 世界の熱疼痛
  • 世界の癌性疼痛
  • 世界の歯科/顔面疼痛
  • 世界の偏頭痛
  • 世界の筋骨格系疼痛
  • 世界の神経因性疼痛
  • 世界の産科疼痛
  • 世界の小児疼痛
  • 世界の術後/外傷性疼痛

第8章 地理区分

  • 南北アメリカの疼痛管理薬市場
  • EMEA地域の疼痛管理薬市場
  • アジア太平洋地域の疼痛管理薬市場

第9章 購入基準

第10章 市場成長因子

第11章 成長因子とその影響

第12章 市場の課題

第13章 成長因子と課題の影響

第14章 市場動向

第15章 動向とその影響

第16章 ベンダー情勢

  • 競合シナリオ
    • 主なニュース
    • M&A
  • 市場シェア分析
  • その他の有力ベンダー

第17章 主要ベンダーの分析

  • Abbott Laboratories
  • Eli Lilly & Co.
  • Pfizer Inc.
  • Endo Health Solutions Inc.
  • Purdue Pharma L.P.

第18章 関連レポート

目次
Product Code: IRTNTR3374

TechNavio's analysts forecast the Global Pain Management Drugs market will grow at a CAGR of 3.84 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing global aging population. The Global Pain Management Drugs market has also been witnessing intense competition among vendors. However, the increase in generic competition could pose a challenge to the growth of this market.

TechNavio's report, the Global Pain Management Drugs Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Pain Management Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

The key vendors dominating this space are Abbott Laboratories, Eli Lilly and Co., Endo Health Solutions Inc., Pfizer Inc., and Purdue Pharma L.P.

The other vendors mentioned in the report are Actavis plc, Allergen Inc., Astra Zenca plc, Baxter International Inc., Bayer Healthcare AG, Boehringer Ingelheim GmbH, Boston Scientific Corp., Bristol Myers Squibb Co., Durect Corp., F. Hoffmann La Roche Ltd., Forest Laboratories Inc., GlaxoSmithKline plc, Hospira Inc., Johnson & Johnson, Merck & Co. Inc., Novartis AG, Pain Therapeutics Inc., Sanofi S.A., St. Jude Medical Inc., UCB S.A., Valeant Pharmaceuticals International Inc., and Zalicus Inc.

Key questions answered in this report:

  • What will the market size be in 2018 and what will be the growth rate?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of each of these key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details provided within the report.

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Market Landscape

  • 06.1. Market Overview
  • 06.2. Market Size and Forecast
  • 06.3. Five Forces Analysis

07. Market Segmentation by Category

  • 07.1. Global Burn Pain Market
    • 07.1.1. Market Size and Forecast
  • 07.2. Global Cancer Pain Market
    • 07.2.1. Market Size and Forecast
  • 07.3. Global Dental/Facial Pain Market
    • 07.3.1. Market Size and Forecast
  • 07.4. Global Migraine Pain Market
    • 07.4.1. Market Size and Forecast
  • 07.5. Global Musculoskeletal Pain Market
    • 07.5.1. Market Size and Forecast
  • 07.6. Global Neuropathic Pain Market
    • 07.6.1. Market Size and Forecast
  • 07.7. Global Obstetrical Pain Market
    • 07.7.1. Market Size and Forecast
  • 07.8. Global Pediatric Pain Market
    • 07.8.1. Market Size and Forecast
  • 07.9. Global Surgical and Trauma Pain Market
    • 07.9.1. Market Size and Forecast

08. Geographical Segmentation

  • 08.1. Pain Management Drugs Market in the Americas
    • 08.1.1. Market Size and Forecast
  • 08.2. Pain Management Drugs Market in the EMEA Region
    • 08.2.1. Market Size and Forecast
  • 08.3. Pain Management Drugs Market in the APAC Region
    • 08.3.1. Market Size and Forecast

09. Buying Criteria

10. Market Growth Drivers

11. Drivers and their Impact

12. Market Challenges

13. Impact of Drivers and Challenges

14. Market Trends

15. Trends and their Impact

16. Vendor Landscape

  • 16.1. Competitive Scenario
    • 16.1.1. Key News
    • 16.1.2. Mergers and Acquisitions
  • 16.2. Market Share Analysis 2013
  • 16.3. Other Prominent Vendors

17. Key Vendor Analysis

  • 17.1. Abbott Laboratories
    • 17.1.1. Business Overview
    • 17.1.2. Business Segmentation
    • 17.1.3. Key Information
    • 17.1.4. SWOT Analysis
  • 17.2. Eli Lilly & Co.
    • 17.2.1. Business Overview
    • 17.2.2. Business Segmentation
    • 17.2.3. Key Information
    • 17.2.4. SWOT Analysis
  • 17.3. Pfizer Inc.
    • 17.3.1. Business Overview
    • 17.3.2. Key Information
    • 17.3.3. SWOT Analysis
  • 17.4. Endo Health Solutions Inc.
    • 17.4.1. Business Overview
    • 17.4.2. Business Segmentation
    • 17.4.3. Key Information
    • 17.4.4. SWOT Analysis
  • 17.5. Purdue Pharma L.P.
    • 17.5.1. Business Overview
    • 17.5.2. Key Information
    • 17.5.3. SWOT Analysis

18. Other Reports in this Series

List of Exhibits:

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Global Pain Management Drugs Market 2013-2018 (US$ billion)
  • Exhibit 3: Global Pain Management Market Segmentation by Category
  • Exhibit 4: Global Pain Management Drugs Market Segmentation 2013
  • Exhibit 5: Global Pain Management Drugs Market by Segments 2013-2018 (US$ million)
  • Exhibit 6: Global Burn Pain Market 2013-2018 (US$ billion)
  • Exhibit 7: Global Cancer Pain Market 2013-2018 (US$ billion)
  • Exhibit 8: Global Dental/Facial Pain Market 2013-2018 (US$ billion)
  • Exhibit 9: Global Migraine Pain Market 2013-2018 (US$ billion)
  • Exhibit 10: Global Musculoskeletal Pain Market 2013-2018 (US$ billion)
  • Exhibit 11: Global Neuropathic Pain Market 2013-218 (US$ billion)
  • Exhibit 12: Global Obstetrical Pain Market 2013-2018 (US$ billion)
  • Exhibit 13: Global Pediatric Pain Market 2013-2018 (US$ billion)
  • Exhibit 14: Global Surgical and Trauma Pain Market 2013-2018 (US$ billion)
  • Exhibit 15: Global Pain Management Drugs Market By Product Segments (in terms of revenue)
  • Exhibit 16: Global Pain Management Drugs Market by Product Segments (percentage)
  • Exhibit 17: Global Pain Management Drugs Market by Geographical Segmentation 2013
  • Exhibit 18: Growth Pain Management Drugs by Geography 2013-2018 (US$ million)
  • Exhibit 19: Global Pain Management Drugs Market by Geography 2013-2018 (Percentage)
  • Exhibit 20: Pain Management Drugs Market in the Americas 2013-2018 (US$ billion)
  • Exhibit 21: Pain Management Drugs Market in the EMEA Region 2013-2018 (US$ billion)
  • Exhibit 22: Pain Management Drugs Market in the APAC Region 2013-2018 (US$ billion)
  • Exhibit 23: Global Pain Management Drugs Market by Geographical Segmentation (in terms of revenue)
  • Exhibit 24: Global Pain Management Drugs Market by Geographical Segmentation
  • Exhibit 25: Global Pain Management Drugs Market by Vendor Segmentation 2013
  • Exhibit 26: Business Segmentation of Abbott Laboratories
  • Exhibit 27: Business Segmentation of Eli Lilly & Co.
  • Exhibit 28: Business Segmentation of Endo Health Solutions Inc.
Back to Top